National Health (Originator Brand) Amendment Determination 2015 (No. 2) (PB 127 of 2015) (Cth)

PB 127 of 2015

National Health (Originator Brand) Amendment Determination 2015 (No. 2)

National Health Act 1953

I, GREG O’TOOLE, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated        21      December 2015

______________________________________

GREG O’TOOLE
Assistant Secretary (Acting)
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

1. Name of Determination

   (1)     This Determination is the National Health (Originator Brand) Amendment Determination 2015 (No. 2).

   (2)     This Determination may also be cited as PB 127 of 2015.

2. Commencement

   This Determination commences on 1 January 2016.

3. Amendments to PB 100 of 2015

   Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

Schedule 1     Amendments

(section 3)

[1]   Schedule 1 (after table item 181)

Insert:

181A Pemetrexed Alimta